8/30/2005

Confronted by a high level of public distrust, the pharmaceutical industry is working to improve its image with curbs on advertising, more drugs for the poor and more disclosure of clinical trial data, The Wall Street Journal reports. Unlike other industries, however, drugmakers do not plan a public-image PR campaign.

Related Summaries